Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Cash Flow-to-Debt Ratio
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow-to-Debt Ratio of -0.31x as of December 2024, meaning its operating cash flow of CN¥-60.52 Million could theoretically repay 0% of its total liabilities (CN¥192.87 Million) in one year. Check Shandong Keyuan Pharmaceutical Co. Ltd. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for Shandong Keyuan Pharmaceutical Co. Ltd. A across 4 annual periods. Also explore Shandong Keyuan Pharmaceutical Co. Ltd. assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)
Year-by-year debt coverage analysis for Shandong Keyuan Pharmaceutical Co. Ltd. A. For market capitalisation and broader financial context, see 301281 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.31x | CN¥-60.52 Million | CN¥192.87 Million | ▼ -217.7% |
| 2023 | 0.27x | CN¥37.03 Million | CN¥138.93 Million | ▼ -69.6% |
| 2022 | 0.88x | CN¥115.86 Million | CN¥132.06 Million | ▲ +116.7% |
| 2021 | 0.40x | CN¥52.02 Million | CN¥128.52 Million | — |